First, this is a pilot study without a comparator group of RA patients not treated with TNF inhibitors, which precludes drawing conclusions about the specific effect of therapy or differentiating outcomes from natural disease evolution or other confounders. The gene discussed is TNF; the disease is rheumatoid arthritis.